Trial Profile
Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of intravenous tapentadol solution for injection for the treatment of post-surgical pain in children aged from birth to less than 2 years, including preterm neonates
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2023
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
- 12 Aug 2023 This trial has been completed in Czechia (Date of the global end of the trial: 27-Sep-2018), according to the European Clinical Trials Database record.
- 20 Feb 2019 This trial has been completed in France, according to European Clinical Trials Database.
- 16 Feb 2019 This trial was discontinued in Hungary, according to European Clinical Trials Database.